Journal of Medicinal Chemistry p. 357 - 366 (1987)
Update date:2022-08-04
Topics:
Lunt, Edward
Newton, Christopher G.
Smith, Christopher
Stevens, Graham P.
Stevens, Malcolm F. G.
et al.
The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at position 6 and 8 and to change the imidazo<5,1-d>-1,2,3,5-tetrazinone (6) skeleton to the isomeric pyrazolo<5,1-d>-1,2,3,5-tetrazino
View MorePuyang Willing Chemicals Co.,Ltd.
Contact:86-393-4840366
Address:Puyang Henan China
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Xinxiang Junlong Biological Technology Co., Ltd.
website:https://junlongbio.lookchem.com/
Contact:86-13525059581
Address:Xinxiang City, Henan Province
Longhui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Qingdao Kylin Trading Co., Ltd.
Contact:0086-532-68979884/58972912/68972263/65/88171519
Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.
Doi:10.1021/acs.orglett.7b03509
(2018)Doi:10.1021/ja00328a031
(1984)Doi:10.1021/ol061123c
(2006)Doi:10.1016/0040-4039(91)80043-6
(1991)Doi:10.1039/b605498f
(2006)Doi:10.1007/BF00515636
(1984)